GlassScriptPhysician profile
Edwin Brian Robbins
NPI 1629184593
$9,890.04
in general payments reported to CMS, 2019-2025
34 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,626 · 2022: $1,604 · 2023: $1,295 · 2024: $5,227 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,046 · Consulting Fee: $2,000 · Travel and Lodging: $1,314 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,045.98 |
| Consulting Fee | $2,000.00 |
| Travel and Lodging | $1,314.42 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $5,819.24 | 2021-2025 | Xifaxan, Relistor, Trulance |
| Collegium Pharmaceutical, INC. | $758.56 | 2021-2024 | Xtampza, Belbuca |
| Nevro Corp. | $442.96 | 2021-2024 | Senza |
| Scilex Pharmaceuticals INC. | $326.79 | 2021-2024 | Ztlido |
| Protega Pharmaceutials INC | $312.44 | 2022-2023 | Roxybond |
| Redhill Biopharma INC. | $198.95 | 2021-2023 | Movantik, Talicia, Aemcolo |
| Teva Pharmaceuticals USA, INC. | $191.54 | 2021-2023 | Ajovy |
| Abbvie INC. | $173.10 | 2021-2024 | |
| Arbor Pharmaceuticals, INC. | $161.72 | 2021-2022 | |
| Amgen INC. | $155.48 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $131.52 | 2021-2022 | |
| Saluda Medical Americas, INC. | $123.24 | 2024-2025 | Evoke |
| Biohaven Pharmaceutical Holding Company LTD. | $122.34 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $119.03 | 2022-2023 | Seglentis |
| Alnylam Pharmaceuticals INC. | $85.41 | 2024 | Givlaari |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $83.75 | 2021 | |
| Pfizer INC. | $80.56 | 2023-2024 | |
| Boston Scientific Corporation | $76.49 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $76.49 | 2025 | Senza |
| Tersera Therapeutics LLC | $57.99 | 2021-2023 | Prialt |
| Azurity Pharmaceuticals, INC. | $50.91 | 2023-2024 | Horizant, Horizant |
| Eisai INC. | $45.59 | 2021 | |
| Novartis Pharmaceuticals Corporation | $41.64 | 2021 | |
| Lilly USA, LLC | $41.42 | 2021 | |
| Almatica Pharma LLC | $38.81 | 2022-2023 | Gralise |
| Pacira Pharmaceuticals Incorporated | $23.38 | 2021 | |
| Lundbeck LLC | $23.12 | 2023 | Vyepti |
| Alkermes, INC. | $22.67 | 2023 | Vivitrol |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.67 | 2021 | |
| Grt US Holding, INC. | $21.49 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.20 | 2021 | |
| Amneal Pharmaceuticals LLC | $15.92 | 2023 | Lyvispah |
| Abbott Laboratories | $14.12 | 2022 | |
| Medtronic, INC. | $13.50 | 2024 | Synchromedii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Robbins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.